Beyond GLP-1: Lilly’s New Amylin Combo Raises the Stakes in Weight Loss
Eloralintide vs. Retatrutide: A Different Way to Target Weight Loss Eloralintide targets amylin receptors, while retatrutide—often called “reta”—targets GLP-1, GIP and glucagon receptors. Both…
Oct 26, 2026